Article: | MedLuna.com

Overview

Journal CMAJ

Date 2020 Oct 6

PMID 33020129

Authors

Theodore Wein

M Patrice Lindsay

David J Gladstone

Alexandre Poppe

Alan Bell

Leanne K Casaubon

Norine Foley

Shelagh B Coutts

Jafna Cox

James Douketis

Thalia Field

Laura Gioia

Jeffrey Habert

Eddy Lang

Shamir R Mehta

Christine Papoushek

William Semchuk

Mikul Sharma

Jacob A Udell

Stephanie Lawrence

Anita Mountain

Gord Gubitz

Dar Dowlatshahi

Anne Simard

Andrea de Jong

Eric E Smith

Affiliations

Soon will be listed here.

References

Cote R, Battista R, Abrahamowicz M, Langlois Y, Bourque F, Mackey A . Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group. Ann Intern Med. 1995; 123(9):649-55. DOI: 10.7326/0003-4819-123-9-199511010-00002. View

Piepoli M, Hoes A, Agewall S, Albus C, Brotons C, Catapano A . 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by.... Eur Heart J. 2016; 37(29):2315-2381. PMC: 4986030. DOI: 10.1093/eurheartj/ehw106. View

Charles C, Gafni A, Whelan T . Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997; 44(5):681-92. DOI: 10.1016/s0277-9536(96)00221-3. View

McNeil J, Nelson M, Woods R, Lockery J, Wolfe R, Reid C . Effect of Aspirin on All-Cause Mortality in the Healthy Elderly. N Engl J Med. 2018; 379(16):1519-1528. PMC: 6433466. DOI: 10.1056/NEJMoa1803955. View

Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G, Barton J . Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus. N Engl J Med. 2018; 379(16):1529-1539. DOI: 10.1056/NEJMoa1804988. View

Meschia J, Bushnell C, Boden-Albala B, Braun L, Bravata D, Chaturvedi S . Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45(12):3754-832. PMC: 5020564. DOI: 10.1161/STR.0000000000000046. View

ODonnell M, Chin S, Rangarajan S, Xavier D, Liu L, Zhang H . Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016; 388(10046):761-75. DOI: 10.1016/S0140-6736(16)30506-2. View

Bibbins-Domingo K . Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016; 164(12):836-45. DOI: 10.7326/M16-0577. View

Johnson R, Huntley A, Hughes R, Cramer H, Turner K, Perkins B . Interventions to support shared decision making for hypertension: A systematic review of controlled studies. Health Expect. 2018; 21(6):1191-1207. PMC: 6250885. DOI: 10.1111/hex.12826. View

10.

Rothwell P, Cook N, Gaziano J, Price J, Belch J, Roncaglioni M . Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials. Lancet. 2018; 392(10145):387-399. PMC: 6083400. DOI: 10.1016/S0140-6736(18)31133-4. View

11.

Sepucha K, Scholl I . Measuring shared decision making: a review of constructs, measures, and opportunities for cardiovascular care. Circ Cardiovasc Qual Outcomes. 2014; 7(4):620-6. DOI: 10.1161/CIRCOUTCOMES.113.000350. View

12.

Grad R, Legare F, Bell N, Dickinson J, Singh H, Moore A . Shared decision making in preventive health care: What it is; what it is not. Can Fam Physician. 2017; 63(9):682-684. PMC: 5597010. View

13.

. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002; 324(7329):71-86. PMC: 64503. DOI: 10.1136/bmj.324.7329.71. View

14.

Belch J, MacCuish A, Campbell I, Cobbe S, Taylor R, Prescott R . The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ. 2008; 337:a1840. PMC: 2658865. DOI: 10.1136/bmj.a1840. View

15.

Wein T, Lindsay M, Cote R, Foley N, Berlingieri J, Bhogal S . Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017. Int J Stroke. 2017; 13(4):420-443. DOI: 10.1177/1747493017743062. View

16.

Vernooij R, Alonso-Coello P, Brouwers M, Martinez Garcia L . Reporting Items for Updated Clinical Guidelines: Checklist for the Reporting of Updated Guidelines (CheckUp). PLoS Med. 2017; 14(1):e1002207. PMC: 5224740. DOI: 10.1371/journal.pmed.1002207. View

17.

Berger J, Brown D, Becker R . Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis. Am J Med. 2008; 121(1):43-9. DOI: 10.1016/j.amjmed.2007.10.002. View

18.

Berger J, Roncaglioni M, Avanzini F, Pangrazzi I, Tognoni G, Brown D . Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA. 2006; 295(3):306-13. DOI: 10.1001/jama.295.3.306. View

19.

Marquis-Gravel G, Roe M, Harrington R, Munoz D, Hernandez A, Jones W . Revisiting the Role of Aspirin for the Primary Prevention of Cardiovascular Disease. Circulation. 2019; 140(13):1115-1124. DOI: 10.1161/CIRCULATIONAHA.119.040205. View

20.

Huang W, Saver J, Wu Y, Lin C, Lee M, Ovbiagele B . Frequency of Intracranial Hemorrhage With Low-Dose Aspirin in Individuals Without Symptomatic Cardiovascular Disease: A Systematic Review and Meta-analysis. JAMA Neurol. 2019; 76(8):906-914. PMC: 6515567. DOI: 10.1001/jamaneurol.2019.1120. View